Del20q MDS Test
Introduction to the Del20q MDS Test
The Del20q MDS test is a specialized genetic test that plays a vital role in diagnosing myelodysplastic syndromes (MDS), a group of disorders caused by poorly formed or dysfunctional blood cells. Understanding genetic abnormalities, such as the deletion of chromosome 20q, is crucial for effective treatment planning and patient management.
What the Test Measures
This test utilizes Fluorescence In Situ Hybridization (FISH) technology to detect chromosomal deletions, specifically focusing on the 20q region. Identifying these genetic changes can provide insight into the prognosis and potential treatment pathways for patients with MDS.
Who Should Consider This Test?
Individuals who exhibit symptoms such as unexplained fatigue, frequent infections, or easy bruising may be candidates for the Del20q MDS test. Additionally, those with risk factors including a family history of blood disorders or previous chemotherapy treatments should consider this test for early detection and management.
Benefits of Taking the Test
- Early detection of myelodysplastic syndromes, leading to timely intervention.
- Informed decision-making regarding treatment options based on genetic findings.
- Enhanced understanding of the disease prognosis and potential outcomes.
Understanding Your Results
Results from the Del20q MDS test will indicate whether chromosomal deletions are present. A healthcare provider will assist in interpreting the results, discussing their implications for treatment and prognosis. It is essential to have a follow-up consultation to understand the next steps based on your results.
Test Pricing
Price Type | Amount (KSh) |
---|---|
Discount Price | 10,500 |
Regular Price | 14,000 |
Convenience Across Kenya
DNA Labs Kenya offers the Del20q MDS test at various branches across the country. We also provide a home sample collection service for your convenience. To book your test or for more information, please call or WhatsApp us at +254711564616.
Pre-Test Instructions
Please note that the Del20q MDS test requires a doctor’s prescription. This test is not applicable for individuals undergoing surgery, pregnant women, or those planning to travel abroad.
Turnaround Time and Sample Type
The turnaround time for results is approximately 3-4 days. The test requires a sample of bone marrow or peripheral blood, collected in a Sodium Heparin Vacutainer (2ml).
Book your Del20q MDS test today and take the first step towards understanding your health better!